41. LOCL-07 LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA. (5th August 2022) Authors: Rechberger, Julian; Khatua, Soumen; Campian, Jian; Sarkaria, Jann; Schwartz, Jonathan; Daniels, David; Schrecengost, Randy Journal: Neuro-oncology advances Issue: Volume 4(2022)Supplement 1 Page Start: i13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
42. Multimodal platform for assessing drug distribution and response in clinical trials. Issue 1 (12th August 2021) Authors: Lopez, Begoña G C; Kohale, Ishwar N; Du, Ziming; Korsunsky, Ilya; Abdelmoula, Walid M; Dai, Yang; Stopka, Sylwia A; Gaglia, Giorgio; Randall, Elizabeth C; Regan, Michael S; Basu, Sankha S; Clark, Amanda R; Marin, Bianca-Maria; Mladek, Ann C; Burgenske, Danielle M; Agar, Jeffrey N; Supko, Jeffrey ... Journal: Neuro-oncology Issue: Volume 24:Issue 1(2022) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
43. NIMG-75. ANALYZING THE INTERFACE BETWEEN MRI AND DRUG DISTRIBUTION USING ORTHOTOPIC GBM-DERIVED XENOGRAFT (PDX) MODELS. (12th November 2021) Authors: Channar, Sameer; Ranjbar, Sara; Jackson, Pamela; Hu, Leland; Regan, Michael; Abdelmoula, Walid; Lopez, Begona; Macura, Slobodan; Agar, Jefferey; Sarkaria, Jann; Agar, Nathalie; Swanson, Kristin Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
44. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma. Issue 1 (8th August 2016) Authors: Hu, Leland S.; Ning, Shuluo; Eschbacher, Jennifer M.; Baxter, Leslie C.; Gaw, Nathan; Ranjbar, Sara; Plasencia, Jonathan; Dueck, Amylou C.; Peng, Sen; Smith, Kris A.; Nakaji, Peter; Karis, John P.; Quarles, C. Chad; Wu, Teresa; Loftus, Joseph C.; Jenkins, Robert B.; Sicotte, Hugues; Kollmeyer, Th... Journal: Neuro-oncology Issue: Volume 19:Issue 1(2017) Page Start: 128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
45. RADT-15. 18F-DOPA PET/CT SURVEILLANCE FOR GLIOBLASTOMA: A RADIOMIC MODEL FROM A PROSPECTIVE PHASE II CLINICAL TRIAL PREDICTING SURVIVAL IN IDH-WILDTYPE, MGMT-UNMETHYLATED PATIENTS. (14th November 2022) Authors: Qian, Jing; Pafundi, Deanna; Breen, William; Brown, Paul; Hunt, Christopher; Jacobson, Mark; Johnson, Derek; Kaufmann, Timothy; Kemp, Bradley; Kizilbash, Sani; Lowe, Val; Ruff, Michael; Sarkaria, Jann; Uhm, Joon; Chan Tseung, Hok Seum Wan; Yan, Elizabeth; Zhang, Yan; Laack, Nadia; Brinkmann, Debra Journal: Neuro-oncology Issue: Volume 24(2022)Supplement 7 Page Start: vii52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
46. RBIO-03. HETEROGENEITY OF HUMAN PATIENT-DERIVED XENOGRAFTS GROWTH RATES RESPONSES TO THE RADIATED MICROENVIRONMENT. (9th November 2020) Authors: zhang, Jibo; Olson, Ian E; Carlstrom, Lucas P; Rahman, Masum; Rajani, Karishma; Gupta, Kshama; Liu, Libo; Tang, Zhi; Sananikone, Eliot F; Dong, Anqin Dong; Warrington, Arthur E; Rodriguez, Moses; Chen, Jincao; Schroeder, Mark A; Ikram, Samar; Sarkaria, Jann; Burma, Sandeep; Burns, Terry C Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
47. RDNA-04. POTENTIAL MECHANISM OF TEMOZOLOMIDE-MEDIATED RADIO-SENSITIZATION IN MGMT HYPERMETHYLATED GLIOBLASTOMA CELLS. (5th November 2018) Authors: Kitange, Gaspar; Smith, Emily; Gupta, Shiv; Sarkaria, Jann Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
48. RTHP-02. IMPACT OF 18F-DOPA PET ON RADIOTHERAPY TARGET VOLUMES FOR NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS; PRELIMINARY RESULTS OF A PHASE II DOSE-ESCALATION TRIAL. (5th November 2018) Authors: Brinkmann, Debra; Pafundi, Deanna; Hunt, Christopher; Lowe, Val; Yan, Elizabeth; D Brown, Paul; Zakhary, Mark; Zhang, Yan; Seaberg, Maasa; seum Wan Chan Tseung, Hok; Sarkaria, Jann; Laack, Nadia Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi225 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
49. SCIDOT-14. ENHANCING BRAIN RETENTION OF A KIF11 INHIBITOR SIGNIFICANTLY IMPROVES ITS EFFICACY IN A MOUSE MODEL OF GLIOBLASTOMA. (11th November 2019) Authors: Gampa, Gautham; Kenchappa, Rajappa; Mohammad, Afroz; Parrish, Karen; Kim, Minjee; Sarkaria, Jann; Rosenfeld, Steven; Elmquist, William Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
50. SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS. (11th November 2019) Authors: Jackson, Pamela; Kim, Minjee; Hawkins-Daarud, Andrea; Singleton, Kyle; Mohammad, Afroz; Burns, Terence; Parney, Ian; Hu, Leland; Kaufmann, Timothy; Elmquist, William; Sarkaria, Jann; Swanson, Kristin Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗